Showing results (31-40 of 90) with videos related to

Sort By:
Pageof 9
Traffic (Copenhagen, Denmark)|June 22, 2011
The polymorphic HCMV glycoprotein UL20 is targeted for lysosomal degradation by multiple cytoplasmic dileucine motifsIvan Jelcic, Johanna Reichel, Christoph Schlude, et al.
European Journal of Immunology|December 10, 2023
The activating receptor NKp65 is selectively expressed by human ILC3 and demarcates ILC3 from mature NK cellsInes Kühnel, Isabel Vogler, Jessica Spreu, et al.
International Journal of Cancer|August 12, 2005
Soluble MICA in malignant diseasesStefan Holdenrieder, Petra Stieber, Andrea Peterfi, et al.
Cancer Immunology, Immunotherapy : CII|April 26, 2006
Soluble MICB in malignant diseases: analysis of diagnostic significance and correlation with soluble MICAStefan Holdenrieder, Petra Stieber, Andrea Peterfi, et al.
Journal of Immunology (Baltimore, Md. : 1950)|August 6, 2005
Activation of V gamma 9V delta 2 T cells by NKG2DBladimiro Rincon-Orozco, Volker Kunzmann, Philine Wrobel, et al.
Proceedings of the National Academy of Sciences of the United States of America|March 3, 2010
Interaction of C-type lectin-like receptors NKp65 and KACL facilitates dedicated immune recognition of human keratinocytesJessica Spreu, Sabrina Kuttruff, Veronika Stejfova, et al.
Blood|October 17, 2008
NKp80 defines and stimulates a reactive subset of CD8 T cellsSabrina Kuttruff, Sven Koch, Alexandra Kelp, et al.
Experimental Hematology|October 20, 2015
Human hematopoietic CD34+ progenitor cells induce natural killer cell alloresponses via NKG2D activationFrancesca Ulbar, Benedetta Nicolini, Gabriella Chirumbolo, et al.
Plos One|August 13, 2025
A common polymorphism in the human immunoreceptor NKp65 determines ligand interaction, cell surface expression and functionJulian Leonard Lino Heller, Yvonne Bartel, Catalin Schach, et al.
Pageof 9